NasdaqGM:RYTMBiotechs
Rhythm Pharmaceuticals (RYTM) Stock Looks Above Fair Value But Sales Stay Strong
Rhythm Pharmaceuticals has delivered very strong share price gains over the past five years, yet the current valuation checks point to a stock that now screens as expensive rather than a clear bargain.
The share price has risen a little more than 6x over the past five years, which puts extra focus on whether that past return is already reflected in today's valuation.
Expectations for continued revenue growth may support the current price, while any setback in execution or higher than...